The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum
Abstract
The generation of many HLA class I peptides entails a final trimming step in the endoplasmic reticulum that, in humans, is accomplished by two 'candidate' aminopeptidases. We show here that one of these, ERAP1, was unable to remove several N-terminal amino acids that were trimmed efficiently by the second enzyme, ERAP2. This trimming of a longer peptide required the concerted action of both ERAP1 and ERAP2, both for in vitro digestion and in vivo for cellular antigen presentation. ERAP1 and ERAP2 localized together in vivo and associated physically in complexes that were most likely heterodimeric. Thus, the human endoplasmic reticulum is equipped with a pair of trimming aminopeptidases that have complementary functions in HLA class I peptide presentation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inspired by models and algorithms developed for detecting contamination in DNA sequencing18, demuxlet is fast, accurate, scalable, and compatible with standard input formats17, 19, 20.”
From Multiplexed droplet single-cell RNA-sequencing using natural genetic variation (2018) · cites this paper as [20]
Citations
Cites
Wessel, D., & Flügge, U. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90782-6 · Cited by 3,997
Genome sequence of the Brown Norway rat yields insights into mammalian evolution
Gibbs, R. A., Weinstock, G. M., Metzker, M. L., Muzny, D. M., Sodergren, E. J., Scherer, S. E., Scott, G., Steffen, D. L., Worley, K. C., Burch, P. E., et al. (2004) · Nature · doi:10.1038/nature02426 · Cited by 2,170
DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDES
Rock, K. L., & Goldberg, A. L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.739 · Cited by 923
ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum
Serwold, T. F., Gonzãlez, F., Kim, J. S., Jacob, R. J., & Shastri, N. (2002) · Nature · doi:10.1038/nature01074 · Cited by 631
A viral inhibitor of peptide transporters for antigen presentation
Früh, K., Ahn, K., Djaballah, H., Sempé, P., Endert, P. V., Tampé, R., Peterson, P. A., & Yang, Y. M. (1995) · Nature · doi:10.1038/375415a0 · Cited by 601
An IFN-γ–induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I–presented peptides
Šarić, T., Chang, S., Hattori, A., York, I. A., Markant, S. L., Rock, K. L., Tsujimoto, M., & Goldberg, A. L. (2002) · Nature Immunology · doi:10.1038/ni859 · Cited by 532
York, I. A., Chang, S., Šarić, T., Keys, J. A., Favreau, J., Goldberg, A. L., & Rock, K. L. (2002) · Nature Immunology · doi:10.1038/ni860 · Cited by 514
Current Protocols in Cell Biology
Bonifacino, J. S., Dasso, M., Harford, J. B., Lippincott‐Schwartz, J., & Yamada, K. M. (2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471143030 · Cited by 509
Producing Nature’s Gene-Chips: The Generation of Peptides for Display by MHC Class I Molecules
Shastri, N., Schwab, S. R., & Serwold, T. F. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064819 · Cited by 304
Endert, P. V., Tampé, R., Meyer, T. H., Tisch, R., Bach, J., & McDevitt, H. O. (1994) · Immunity · doi:10.1016/1074-7613(94)90091-4 · Cited by 287
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–482 of 482
Ligand Selection and Trafficking for MHC I
van Hateren, A., & Elliott, T. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.06008-2 · Cited by 1
Multifactorial remodeling of the cancer immunopeptidome by interferon gammaPreprint
Newey, A., Yu, L., Barber, L. J., Choudhary, J. S., Bassani‐Sternberg, M., & Gerlinger, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.23.485466 · Cited by 1
Editorial: Insights in antigen presenting cell biology: 2021
Endert, P. V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1079913 · Cited by 1
Dabke, K., Gull, N., Kreimer, S. D., Peng, P.-C., Diaz, M., Cheikh, B. B., Dhawan, A., Evans, K., Ng, N. D., Yuan, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.01.655822 · Cited by 1
Autoimmunity – Diseases of the EYE
Ghadiri, N., & Castillo, M. L. D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00260-x · Cited by 1
Fritsch-Stork, R. D. E. (2014) · Utrecht University Repository (Utrecht University)
Adegoke, A. (2015) · Memorial University Research Repository (Memorial University)
Antigen presentation. How sweet
Boes, M. L., & Bogaert, D. (2010)
MHC Class I Ligands and Epitopes in HRSV Infection
López, D. (2011) · InTech eBooks · doi:10.5772/26449
HLA Class I Antigen Abnormalities in Tumors
Seliger, B., & Ferrone, S. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6087-8_6
Structural Investigations of MHC Class II Conformers
Günther, S. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13966
Martha, E., López-Delgado, H. A., Valadez‐Moctezuma, E., Scott, I. M., Røder, G., Geironson, L., Follin, E., Thuring, C., & Paulsson, K. M. (2012) · InTech eBooks · doi:10.5772/48010
Towne, C. F. (2006) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/qdrg-pn23
Structural and Functional Studies of Proteins Involved in Antigen Processing: A Dissertation
Nguyen, T. T.-T. N. (2010) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/6z0d-jb74
Inmunoproteómica aplicada a la presentación de péptidos virales por moléculas de MHC de clase I
Esteban, S. I. (2011) · Biblos-e Archivo (Universidad Autónoma de Madrid)
Untersuchung der proteolytischen Prozessierung von humanen Angiotensin-Peptiden
Hildebrand, D. (2013)
On the Source of Peptides for Major Histocompatibility Class I Antigen Presentation: A Dissertation
Farfán-Arribas, D. J. (2012) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/23eg-3c30
Sever, L. (2014) · UWSpace (University of Waterloo)
ERAAP prevents leader dominance?
Colaco, C. A. L. S. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.61
Origin and Processing of MHC-I Ligands
Endert, P. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.06007-0
Reiser, M. L. (2011) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-2324
Endoplasmic Reticulum Aminopeptidase 2
Endert, P. V., & Saveanu, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00087-9
Self-citationFactoring in Antigen Processing in Designing Antitumor T-Cell Vaccines
́vy, F. ́. ́. L., Colombetti, S., Janda, J. M., & Chapatte, L. (2008) · doi:10.3109/9781420054682-3
Akram, A. (2014) · TSpace (University of Toronto)
Application of Antigen Cross-Presentation Research into Patient Care
(2017) · Frontiers research topics · doi:10.3389/978-2-88945-191-3
Rock, K. L., York, I. A., Bhutani, N., Zendzian, S., & Alfred, L. J. (2017)
Novel Insights in Ankylosing Spondylitis Biology: Mouse and Human Studies
Lin, A. (2018) · TSpace (University of Toronto)
Schomburg, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00085-5
Self-citationDabak, R., Sezgin, G., Kaya, F. O., Akgün, F. S., Bayramıçlı, O. U., & Nalbant, S. (2020) · Acta Scientific Gastrointestinal Disorders · doi:10.31080/asgis.2020.03.0194
Viral evasion of the MHC class I antigen presentation pathway It's a T(r)AP
Praest, T. P. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/552
Racial Differences in the Genetics of Preeclampsia
Hill, L. D. (2011) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/5cyj-h864
Investigating the mechanisms of ankylosing spondylitis-associated genetic variants
Whyte, J. (2021) · Queensland University of Technology · doi:10.5204/thesis.eprints.211291
Cherciu, L. I., Cherciu, M., Popa, L. O., Bojincă, M., Dutescu, M. I., Bojinca, V. C., Bara, C., & Popa, O. M. (2016) · Romanian Journal of Rheumatology · doi:10.37897/rjr.2016.2.4
ERAP1 GENE POLYMORPHISMS INFLUENCE THE CLINICAL CHARACTERISTICS OF ANKYLOSING SPONDYLITIS
Cherciu, M., Popa, L. O., Bojincă, M., Dutescu, M. I., Bojinca, V. C., Şerban, T., Bara, C., & Popa, O. M. (2015) · Romanian Journal of Rheumatology · doi:10.37897/rjr.2015.2.5
Assaying Peptide Translocation by the Peptide Transporter TAP
Jongsma, M. L. M., & Neefjes, J. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-218-6_5
Factoring in Antigen Processing in Designing Antitumor T-Cell Vaccines
Lévy, F., Colombetti, S., Janda, J., Chapatte, L., Alves, P. M. S., Casado, J. G., Lévy, N., & Peitrequin, A.-L. (2008) · Translational medicine series · doi:10.3109/9781420054682.001
Raghavan, M., Zaitouna, A. J., & Kaur, A. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733858020.793578407
Grundlagen der Tumorimmunologie
Theobald, M., Brossart, P., & Seliger, B. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-46764-0_265-1
Discovery of the First Selective Nanomolar Inhibitors of ERAP2 by Kinetic Target‐Guided Synthesis
Camberlein, V., Fléau, C., Sierocki, P., Li, L., Gealageas, R., Bosc, D., Guillaume, V., Warenghem, S., Leroux, F., Rosell, M., et al. (2022) · Angewandte Chemie · doi:10.1002/ange.202203560
Pharmacogenetics of Cutaneous Adverse Drug Reactions
Yip, V. L. M., & Pirmohamed, M. (2022) · Updates in clinical dermatology · doi:10.1007/978-3-031-09388-3_1 · Cited by 1
Krige, D., Needham, L. A., Bawden, L. J., Flores, N., Farmer, H., Miles, L. E. C., Stone, E. L., Callaghan, J., Chandler, S., Clark, V. L., et al. (2023) · doi:10.1158/0008-5472.c.6497138.v1
Krige, D., Needham, L. A., Bawden, L. J., Flores, N., Farmer, H., Miles, L. E. C., Stone, E. L., Callaghan, J., Chandler, S., Clark, V. L., et al. (2023) · doi:10.1158/0008-5472.c.6497138
Dilek, Y. E., Kara, İ., Kıvrak, S., Özkaya, Ş. Ç., Erzık, C., Abacar, K., Atagündüz, P., & Akçapınar, G. B. (2023) · Research Square · doi:10.21203/rs.3.rs-2718824/v1
ERAP1 shows distinct regulatory mechanisms on blood pressure modulation between males and femalesPreprint
Ding, M., Heydarpour, M., Gomez, D. H., Aljaibeji, H., Parksook, W. W., Peng, L., Pojoga, L. H., Romero, J. R., & Williams, G. H. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.07.544152
Understanding the role UFMylation plays in prostate cancer
Stephenson, S. (2024) · Queensland University of Technology · doi:10.5204/thesis.eprints.246676
Abbas, M. A., Masry, M. A. A., ALQusi, S. M., Hadhoud, M. M., & Fouda, E. A.-A. M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09733-w
Ligand Selection and Trafficking for MHC I
van Hateren, A., & Elliott, T. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00117-4
Origin and Processing of MHC I Ligands
Endert, P. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00116-2
THE UNCHARTED ROLE OF ERAP2 IN AGING: A BIOINFORMATICS PERSPECTIVEPreprint
Akbar, A. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.30.646199
Słomiński, B., Gładysz, J., Skrzypkowska, M. W., Ryba-Stanisławowska, M. E., Nowicki, D., Szalewska-Pałasz, A., & Myśliwiec, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112287
Endoplasmic reticulum aminopeptidase 2
Endert, P. V., & Saveanu, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28849-4.00009-6
Self-citationSchomburg, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-28849-4.00008-4
Self-citationWu, X., Luo, Q., Luo, X., Liu, D., Li, F., Ma, C., & Tang, X. (2025) · Pediatric Rheumatology · doi:10.1186/s12969-025-01140-0
Cancer Antigens: Sources, Generation, and Presentation
Joyce, S. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_38
Mohandes, S., Hirohama, D., Ha, E., Dumoulin, B., Pan, S., Bergeson, A., Abedini, A., Nguyen, T., McAllister, F. E., & Suszták, K. (2025) · medRxiv · doi:10.1101/2025.10.02.25337157
Ding, J. (2010) · Deep Blue (University of Michigan)
Li, C., Li, Y., Yan, Z., 戴书颖, Liu, S., Wang, X., Wang, J., Zhang, X., Shi, L., & Yao, Y. (2020) · Figshare · doi:10.6084/m9.figshare.12177930
Zinc-dependent aminopeptidases: new perspectives on structure, function, and biomedical applications
Bhat, S. Y. (2026) · Frontiers in Chemical Biology · doi:10.3389/fchbi.2026.1752191
Bai, J., Wu, Z., Wan, Z., Zhao, C., Liu, Y., & Wang, T. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101457
Kourjian, G. (2015) · theses.fr (ABES) · doi:10.70675/b41647f7zdd56z465cz9213zc11fff98c2ca
Caractérisation des mécanismes de présentation des antigènes par les molécules du CMH-II
Pereira, M. (2019) · theses.fr (ABES) · doi:10.70675/25b7a7caz4e43z48efz87eaz12c10ef4ba1c
ERAP2はUPRシグナル伝達経路を介した膵星細胞のオートファジーと活性化における新たな標的である
Guan, W. (2022) · Institutional Repositories DataBase (IRDB)
Moonlighting ERAP Aminopeptidases in Cancer: Beyond Antigen Processing
Gragera, P., Scaldaferri, V., & Fruci, D. (2026) · Cells · doi:10.3390/cells15171609
Self-citationMultiple bottlenecks constrain presentation of Mycobacterium tuberculosis antigens on MHC class IPreprint
Leddy, O. K., Gunnarsson, C., Holec, P. V., Ren, D., Martello, C., Birnbaum, M. E., White, F. M., & Bryson, B. D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.16.759551
BindingDB (2025) · UC San Diego · doi:10.7270/q2pn9b72
BindingDB Entry 50013831: Modulators of hERAP2 discovered by high-throughput screening.
BindingDB (2022) · UC San Diego · doi:10.7270/q29z98pr
BindingDB (2014) · UC San Diego · doi:10.7270/q2j38v00
Metadata
- Authors
- Saveanu, L., Carroll, O., Lindo, V., Del Val, M., Lopez, D., Lepelletier, Y., Greer, F., Schomburg, L., Fruci, D., Niedermann, G., & van Endert, P. M.
- Affiliations
- Inserm (FR)
- Centre National de la Recherche Scientifique (FR)
- Charité – Universitätsmedizin Berlin (DE)
- Max Planck Society (DE)
- Venue
- Nature Immunology
- Published
- 2005-05-22
- Volume
- 6
- Issue
- 7
- Pages
- 689-697
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1981338942
- Cited by
- 481
- References
- 35
- Citations by year
- 2026: 8 · 2025: 18 · 2024: 18 · 2023: 31 · 2022: 20 · 2021: 23 · 2020: 28 · 2019: 30 · 2018: 25 · 2017: 25 · 2016: 15 · 2015: 26 · 2014: 25 · 2013: 31 · 2012: 27
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- Comunidad de Madrid
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Peptidase Inhibition and Analysis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- ERAP1, ERAP2, aminopeptidase, peptide trimming, HLA class I, endoplasmic reticulum, antigen presentation
- MeSH terms
- Aminopeptidases, Epitopes, Endoplasmic Reticulum, HeLa Cells, Humans, Microsomes, Peptide Fragments, RNA, Immunoblotting, Histocompatibility Antigens Class I, Minor Histocompatibility Antigens, Antigen Presentation, Reverse Transcriptase Polymerase Chain Reaction, RNA Interference
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review